Founder and Trustees
Dr Peter Sowerby

peter_sowerbyPeter co-founded Egton Medical Information Systems Limited (EMIS) with fellow GP Dr David Stables in 1987. The two GPs had written the software for an electronic medical record system for use by GPs whilst working at Egton Surgery in Egton near Whitby, North Yorkshire. The resulting company, EMIS has grown over more than 25 years to be the largest supplier of clinical information systems to General Practitioners in the UK. In 2011, Peter Sowerby Foundation was established as a charitable trust to direct Peter’s personal wealth to meet his philanthropic objectives and those of his late wife, Ann. In April 2013, the Foundation was incorporated as a company limited by guarantee (no. 08492424) and was registered with the Charity Commission in May 2013 (charity no. 1151978).

The Trustees of the Foundation are:
David Aspinall

david_aspinallDavid Aspinall has been Chairman of the Peter Sowerby Foundation since its establishment in 2011. David is also founder and Executive Chairman of Aspinalls, an advisory firm delivering personal financial planning and wealth management services to private clients. He is a trustee of the National Youth Choirs of Great Britain as well as acting as executor and trustee to many clients, their trusts and charities. A music graduate and former university organ scholar, David remains an active musician and also has keen interests in horticulture, historic garden landscapes, archaeology and the performing arts.

Sara Siegel Poulios

Sara Siegel PouliosSara is a lead partner in Deloitte’s Healthcare Strategy practice and has worked with the NHS and the Department of Health for the last eleven years on major policy implementations. She was seconded to the Department of Health to help write ‘Our health, our care, our say’, then worked with the NHS on Foundation Trust assessments, shifting care, Transforming Community Services, World Class Commissioning and GP Commissioning. She also works with private sector health companies on growth strategy and policy impact. She has worked with dozens of Primary Care Trusts/Clinical Commissioning Groups, acute trusts and community providers on questions of sustainability and clinical service change.

Sara leads Deloitte’s analytics work for healthcare including the dashboards they provide nationally to the NHS providing data on workforce metrics and quality performance at an organisational level. Sara is a graduate of Northwestern University and holds an MBA from INSEAD.

Dr David Stables

rsz_d-prof-portDavid has over 25 years’ experience in healthcare IT. Having qualified in Medicine at Dundee University in 1981, he entered general practice in 1984 at Egton Surgery in North Yorkshire working as a Partner in that practice from 1987 to 1991 alongside Dr Peter Sowerby. Together they developed the patient records management software that subsequently formed the basis of the business of EMIS. He was appointed Medical Director of EMIS in 1987 and went on to lead the EMIS software development team with responsibility for software requirements, design, technology and clinical assurance, including the current EMIS Web system.

David served as a Director of Strategic Development at EMIS Group PLC from 2009 to September 30, 2013 and was responsible for the Group’s future product strategy, including specification of software functionality, software design and architecture. Other responsibilities included clinical research using EMIS IT and technical research for next generation technologies relevant to healthcare.

David is a Trustee of the Endeavour Health Charitable Trust whose objectives are to enable the design of, and research the effectiveness of, new forms of healthcare information technology and healthcare provision with particular emphasis on patients as users of IT.

Professor Carole Longson

Carole is Chief Scientific Officer at The Association of the British Pharmaceutical Industry.She was previously Director of the Centre for Health Technology Evaluation at NICE. She has a doctorate in Pharmacology and spent 8 years at GlaxoSmithKline Research working on the development of novel pharmaceuticals in various therapeutic areas.

Carole has previously been involved in health technology assessment as Director of the Evidence Research Unit. She contributes to a number of international policy forums, including the WHO advisory group on Priority Medical Devices and the Scientific Committee of the Innovative Medicines Initiative. She is Honorary Professor of Health Technology Assessment at the University of Manchester, UK and past President of Health Technology Assessment International (2013 to 2015).